Longitudinal 18F-FMISO micro-PET/CT imaging (Fig 4A) was investigated during endocrine therapy for ER+ breast cancer in ZR-75-1 xenografts because of its suitability for determining hypoxia in solid tumors. This evidence concerns the gene ESR1 and breast carcinoma.